Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Liver Int. 2016 Jul 6;36(12):1783–1792. doi: 10.1111/liv.13177

Table 1.

Baseline demographic, clinical and laboratory parameters

All (n=18) HCV (n=6) HIV/HCV (n=8) HIV (n=4)
Age, years (median, range) 57 (45–65) 59 (49–63) 53 (45–61) 55 (50–65)
Male sex, n (%) 14 (78%) 3 (50%) 7 (87%) 4 (100%)
Self-reported Race and Ethnicity, n (%)
 Black, not Hispanic/Latino 6 (33%) 2 (33%) 4 (50%) 0 (0%)
 White, not Hispanic/Latino 8 (44%) 4 (67%) 2 (25%) 2 (50%)
 American Indian 1 (6%) 0 1 (13%) 0
 Hispanic/Latino 3 (17%) 0 1 (12%) 2 (50%)
Body mass index, kg/m2 (median, range) 30 (21–46) 32 (22–45) 30 (21–46) 30 (28–32)
Alkaline phosphatase, U/L(median, range) 102 (61–210) 89 (61–143) 114 (82–119) 112 (75–210)
Aspartate aminotransferase (AST), U/L (median, range) 63 (31–151) 96 (31–151) 56 (43–96) 66 (49–116)
Alanine aminotransferase (ALT), U/L (median, range) 84 (37–161) 106 (46–144) 58 (37–90) 98 (67–161)
Total bilirubin, mg/dL (median, range) 0.8 (0.3–2.3) 0.7 (0.4–1.3) 0.8 (0.3–2.3) 0.9 (0.4–1.6)
Platelets, K/uL (median, range) 152 (45–250) 132 (75–239) 180 (45–250) 138 (57–166)
Hepatitis C genotype, n (%)
 1a 5 (83%) 7 (88%) NA
 1b 1 (17%) 1 (12%) NA
Hepatitis C treatment experienced, n (%) 4 (66%) 6 (75%) NA
HIV viral load, copies/mL (median, range) NA <40 (<40–220) <40 (<40–172)
CD4 count, cells/mm3 (median, range) 572 (123–2558) 976 (410–2558) 572 (173–1049) 189 (123–260)
Hepatic venous portal gradient (HVPG), mmHg (median, range) 9 (3–15) 10 (4–12) 7 (3–15) 7 (3–15)
 HVPG≥10mmHg, n (%) 6 (33%) 3 (50%) 2 (25%) 1 (25%)
Liver biopsy
 Length, mm (median, range) 14 (5–24) 13 (6–18) 13 (5–18) 15 (9–24)
 Ishak fibrosis score (median, range) 5 (3–6) 6 (3–6) 4 (3–6) 5 (3–6)
 Ishak inflammation score (median, range) 8 (4–14) 8 (4–9) 9 (8–14) 6 (4–9)
 Steatosis (median, range) Trace (0–2) Trace (0–1) Trace (0–2) 2 (Trace–2)